COVID-19 Immunity Task Force

The COVID-19 Immunity Task Force (CITF) is one of the Government of Canada's early efforts to track the 2020 coronavirus pandemic.[1] An external, dedicated secretariat will help maximize the efficiency of the CITF's work.[2]

Task Force membership

The CITF Board is composed of doctors, infectious disease experts, and policy makers. Its charter members were five:[1]

The CCITF board expanded on 2 May 2020. Its additional members are:[3]

  • Stephen Lucas
  • Carrie Bourassa
  • Scott Halperin
  • Charu Kaushic
  • James D. Kellner
  • Susan Kirkland
  • Gary Kobinger
  • Mel Krajden
  • Richard Masse
  • Allison McGeer
  • Deborah Money
  • Gina Ogilvie
  • Kevin Orrell
  • Jutta Preiksaitis
  • Caroline Quach Thanh
  • James Talbot
  • Paul Van Caeseele

Purpose and goals

The CITF was to use a serology "to survey representative samples of the population for the presence of antibodies to the virus".[4] Trudeau's press release on 23 April 2020, on the initiation of the CCITF listed several goals it would help to achieve notably that it would:[2]

establish priorities and oversee the coordination of a series of country-wide blood test surveys that will tell us how widely the virus has spread in Canada and provide reliable estimates of potential immunity and vulnerabilities in Canadian populations.


  1. ^ a b "WHO set pandemic response back by 2-3 weeks, says doctor on new federal task force". CBC. 23 April 2020.
  2. ^ a b "Prime Minister announces new support for COVID-19 medical research and vaccine development". Justin Trudeau, Prime Minister of Canada. 23 April 2020.
  3. ^ Letterhead of CCITF: List of Members - CCITF Leadership Group (Tweet photo from C. David Naylor)
  4. ^ "Canada launches serological testing initiative to help manage COVID-19". McGill University Institutional Communications. 23 April 2020.

External links

Media files used on this page

SARS-CoV-2 (Wikimedia colors).svg
Author/Creator: Geraki, Licence: CC BY-SA 4.0
SARS-CoV-2 logo in Wikimedia colors
SARS-CoV-2 without background.png
This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses. Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically. A novel coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19).
Érable canada.svg
Author/Creator: The original uploader was Bilou~commonswiki at Wikimedia Commons. Updated image provided by MapGrid., Licence: CC-BY-SA-3.0
icône pour articles sur le cananda